Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression
- 31 May 2005
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 42 (5) , 687-693
- https://doi.org/10.1016/j.jhep.2004.12.025
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in miceHepatology, 2004
- Angiogenesis in health and diseaseNature Medicine, 2003
- Tumorigenesis and the angiogenic switchNature Reviews Cancer, 2003
- Hepatocellular carcinoma: Diagnosis and treatmentGastroenterology, 2002
- Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical studyJournal of Hepatology, 2001
- Angiogenesis in cancer and other diseasesNature, 2000
- Angiogenesis is an early event in the generation of myc-induced lymphomasOncogene, 2000
- Initial Stages of Tumor Cell-Induced Angiogenesis: Evaluation Via Skin Window Chambers in Rodent ModelsJNCI Journal of the National Cancer Institute, 2000
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in MiceScience, 1999
- Hepatocellular carcinomaThe Lancet, 1999